Plasmid

Pathogenic resistance, the phenomenon where pathogens develop the ability to withstand treatments meant to eliminate them, presents a significant challenge in healthcare and drug discovery. This escalating problem not only threatens the effectiveness of current treatments but also underscores the critical need for innovative approaches to combat resistance. At Plasmid.AI, our approach aims to address this issue by harnessing the power of artificial intelligence to create novel synthetic plasmid-based toxin-antitoxin systems. These AI-generated systems are designed to specifically neutralize antibiotic-resistant pathogens, offering a fresh and potent approach to combat this global health threat.